Clover Health Reports First Profitable Quarter, Projects Full-Year GAAP Net Income for 2026

summarizeSummary

Clover Health announced strong Q1 2026 results, achieving positive GAAP Net Income for the first time and projecting full-year GAAP Net Income profitability, driven by significant revenue and membership growth.

check_boxKey Events · Earnings and Guidance · CLOV

• Achieves Q1 GAAP Net Income

  Clover Health reported GAAP Net Income of $27.3 million for Q1 2026, a significant improvement from a net loss of $1.3 million in Q1 2025.

• Projects Full-Year GAAP Profitability

  The company provided full-year 2026 guidance for GAAP Net Income between $0 million and $20 million, indicating an expectation to achieve its first full year of GAAP Net Income profitability.

• Strong Revenue and Membership Growth

  Total revenues increased 62.1% year-over-year to $749.2 million, while Medicare Advantage membership grew 51% to 155,773 members in Q1 2026.

• Positive Adjusted EBITDA

  Adjusted EBITDA for Q1 2026 was $40.3 million, up 56.2% from $25.8 million in the prior year period.

auto_awesomeAnalysis · CLOV · Finance

Clover Health's Q1 2026 results mark a significant turnaround, with the company achieving positive GAAP Net Income for the first time, a substantial improvement from a net loss in the prior year. This positive performance is further bolstered by strong growth across key metrics, including a 62% year-over-year increase in total revenues and a 51% rise in Medicare Advantage membership. The company's guidance for full-year 2026 GAAP Net Income profitability is a critical development, signaling a potential shift in its financial trajectory after a period of losses, as highlighted by the negative financial baseline from the last 10-K and the impact on 2025 executive compensation. Investors should monitor the company's ability to sustain this profitability and meet its full-year guidance.